How I Invest with David Weisburd
E131: Can VCs Make Money in Deep Tech? w/Nick Shekerdemian
Jan 21, 2025
Join Nick Shekerdemian, founding partner of The Venture Collective and former Thiel Fellow, as he dives into the world of deep tech and venture capital. He shares insights on his transformative journey from Oxford to entrepreneurship, revealing how thesis-driven investing can propel meaningful innovation. Nick discusses the complexities of seed-stage investments, the significance of transparency with founders, and the potential of AI in revolutionizing healthcare and bio-defense. Explore the future of transformative technologies and the challenges in scaling visionary ideas.
28:38
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Nick Shekerdemian emphasizes the importance of thesis-driven investing in deep tech and computational biology as the future of venture capital.
- The podcast highlights the critical role of relationship management in overcoming challenges like founder breakups to enhance startup success.
Deep dives
The Emerging Threat of Bioweapons and AI
The potential use of bioweapons is becoming a significant concern, especially with advancements in artificial intelligence. AI has the capability to create new protein structures that could effectively evade traditional vaccines, leading to a terrifying future in biodefense. This necessitates a substantial rethink in how vaccines and therapeutics are developed, with a focus on arming the body in a personalized manner. As the landscape of defense evolves, it is crucial for experts to explore these threats to enhance biodefense capabilities.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
